Apixaban 2.5 mg/1 (Apixaban TABLET, FILM COATED) 2.5 mg/1

Apixaban 2.5 mg is an oral medication used to prevent blood clots. This film-coated tablet is manufactured by Macleods Pharmaceuticals Limited and is commonly prescribed for conditions related to blood thinning.

Strength

2.5 mg/1

Pack Size

10 BLISTER PACK in 1 CARTON (33342-337-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

Macleods Pharmaceuticals Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Apixaban 2.5 mg is primarily used to reduce the risk of blood clots in individuals with certain medical conditions. It is often prescribed for preventing deep vein thrombosis (DVT) and pulmonary embolism (PE). Patients may also use Apixaban for other conditions as directed by their healthcare provider. Understanding what Apixaban is used for can help in managing treatment plans effectively.

Side Effects

Common effects of Apixaban 2.5 mg may include bruising, bleeding, and minor stomach discomfort. Some users might experience dizziness or fatigue. These effects vary among individuals and are not exhaustive. Always consult a healthcare professional for personalized advice.

Precautions & Warnings

Apixaban 2.5 mg should be handled with care, especially in patients with a history of bleeding disorders. It is important to follow the prescribed dosage and storage instructions. Avoid activities that may increase the risk of injury or bleeding while using this medication.

Avoid Interactions

Apixaban 2.5 mg may interact with certain medications, including other blood thinners and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be moderated, as it can affect the medication's efficacy. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Apixaban 2.5 mg is used to prevent blood clots in conditions like deep vein thrombosis and pulmonary embolism.

Store Apixaban 2.5 mg at room temperature, away from moisture and heat.

Common side effects may include bruising, bleeding, and minor stomach discomfort.

Apixaban 2.5 mg may interact with other medications, so always consult a healthcare provider before combining treatments.

Apixaban 2.5 mg may not be suitable for individuals with certain medical conditions or allergies. Always consult a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.